Publication Name	World Journal of Gastroenterology
Manuscript ID	851
Country	Spain

Received	2012-10-18 19:35
Peer-Review Started	2012-10-19 14:26
First Decision by Editorial Office Director
Return for Revision	2012-11-09 14:02
Revised	2012-12-09 22:59
Publication Fee Transferred
Second Decision by Editor	2012-12-17 11:15
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2012-12-17 12:12
Articles in Press
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-01-24 18:45
Publish the Manuscript Online	2013-01-29 16:05

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab
Manuscript Source	Invited Manuscript
All Author List	Ileana Duca, Patricia Ramírez de la Piscina, Silvia Estrada, Rosario Calderón, Katerina Spicakova, Leire Urtasun, Carlos Marra-López, Salvador Zabaleta, Raquel Bengoa, María Asunción Marcaide and Francisco García-Campos
Funding Agency and Grant Number
Corresponding Author	Patrícia Ramírez de la Piscina, MD, Service of Gastroenterology, Hospital Universitario de Álava-Sede Txagorritxu, Universidad del País Vasco, C/ José Achótegui s/n, E-01009 Vitoria-Gasteiz, Spain. patricia.ramirezdelapiscinaurraca@osakidetza.net
Key Words	Ulcerative colitis; Infliximab; Monoclonal antibodies; Sclerosing cholangitis; Bile duct diseases; Tumor necrosis factor-alpha
Core Tip
Publish Date	2013-01-29 16:05
Citation	Duca I, Ramírez de la Piscina P, Estrada S, Calderón R, Spicakova K, Urtasun L, Marra-López C, Zabaleta S, Bengoa R, Marcaide MA, García-Campos F. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab. World J Gastroenterol 2013; 19(4): 590-593
URL	http://www.wjgnet.com/1007-9327/full/v19/i4/590.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i4.590

Full Article (PDF)	WJG-19-590.pdf
Manuscript File	851-Review.doc
Answering Reviewers	851-Answering reviewers.pdf
Copyright License Agreement	851-Copyright assignment.pdf
Peer-review Report	851-Peer reviews.docx
Scientific Editor Work List	851-Scientific editor work list.doc